United Therapeutics Files 2024 10-K
Ticker: UTHR · Form: 10-K · Filed: Feb 26, 2025
Sentiment: neutral
Topics: 10-K, annual-report, pharmaceuticals
TL;DR
UTHR filed its 2024 10-K. Full financials and biz details out.
AI Summary
United Therapeutics Corporation filed its 2024 10-K on February 26, 2025, reporting on its fiscal year ending December 31, 2024. The company, based in Silver Spring, MD, operates in the pharmaceutical preparations sector. Key financial details and operational highlights for the fiscal year are presented in this comprehensive annual report.
Why It Matters
This filing provides investors and stakeholders with a detailed overview of United Therapeutics' financial performance, strategic initiatives, and risk factors for the 2024 fiscal year, crucial for understanding the company's current standing and future outlook.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, United Therapeutics faces inherent risks related to drug development, regulatory approvals, market competition, and patent expirations.
Key Players & Entities
- UNITED THERAPEUTICS Corp (company) — Filer
- 20241231 (date) — Fiscal Year End
- 20250226 (date) — Filing Date
- SILVER SPRING (location) — Business Address City
- MD (location) — Business Address State
- 20910 (postal_code) — Business Address Zip
- 3016089292 (phone_number) — Business Phone
FAQ
What is United Therapeutics Corporation's primary business sector?
United Therapeutics Corporation operates in the Pharmaceutical Preparations sector, with the SIC code 2834.
When did United Therapeutics Corporation file its 2024 10-K report?
The 10-K report for the fiscal year ending December 31, 2024, was filed on February 26, 2025.
Where is United Therapeutics Corporation headquartered?
United Therapeutics Corporation's business and mailing address is 1000 Spring St, Silver Spring, MD 20910.
What is the SEC file number for United Therapeutics Corporation?
The SEC file number for United Therapeutics Corporation is 000-26301.
What is the fiscal year end for United Therapeutics Corporation?
The fiscal year end for United Therapeutics Corporation is December 31.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on February 26, 2025 regarding UNITED THERAPEUTICS Corp (UTHR).